Bosch Introduces New HQL Sterilization Tunnel Series
At Interpack 2014, Bosch Packaging Technology, a leading supplier of process and packaging technology, presents the new 6000, 7000 and 8000 series of the HQL drying and sterilization tunnel. This new generation of tunnels is an energy-saving and especially flexible advancement of the proven HQL series for sterilizing and depyrogenizing pre-cleaned ampoules, injection and infusion bottles, as well as cartridges and syringes.
The modular design of the HQL series ensures a customer-specific tunnel arrangement. Each sterilizing and cooling module contains the entire technology for the respective process step. “The modules can now be variably put together. This allows the new series to be flexibly integrated into different line concepts,” Matthias Angelmaier, product manager at Bosch Packaging Technology, explains. In addition, the new design facilitates access to critical areas such as HEPA filters, which can be easily replaced, thus simplifying maintenance of the tunnels.
Savings in Energy and Space
Pharmaceutical manufacturers profit from the increased energy efficiency of the new HQL series. In contrast to most sterilization tunnels, the new series requires less energy for electrical heating and ventilation due to an optimized airflow and measures for heat recovery. A flexible pressure zone concept ensures increased process safety by adapting tunnel pressures in the different zones to customers' requirements. The new tunnels are further characterized by a reduced overall tunnel size, making them shorter and more space-saving than the previous series.
Three Standardized Conveyor Belt Sizes
The new tunnels are available in three standardized bandwidths of 600 respectively 800 mm for the HQL 6000 and 7000 and 1 200 mm for the HQL 8000, which is on display at Interpack. With its different sizes, the drying and sterilization tunnel can be flexibly adapted to different requirements.
“Based on the physical properties of our customers' packaging material we calculate, which tunnel modules are adequate for their processes,” Angelmaier explains. This subsequently facilitates safe process validation and documentation. “The HQL 8000, for instance, with its broad conveyor belt and several sterilizing and cooling modules is suited for large glass containers and downstream filling machines with high output.” The horizontal transport belt made of a stainless steel wire mesh makes sure all freestanding and non-freestanding containers are transported through the HQL tunnel gently and without abrasion.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.